Results 91 to 100 of about 847 (163)

Sustained response to atogepant in episodic migraine

Atogepant is an oral calcitonin gene-related peptide receptor antagonist approved for the preventive treatment of migraine in adults. These analyses evaluated the proportions of clinical trial participants who experienced sustained responses to atogepant over 12 or 52 weeks of treatment. These were post hoc analyses of ADVANCE, a 12-week, double-blind,
Lipton, Richard, Nahas, Stephanie J.||, Pozo-Rosich, Patricia||, Bilchik, Tanya, McAllister, Peter, Finnegan, Michelle, Liu, Yingyi, Chalermpalanupap, Natty, Dabruzzo, Brett, Dodick, David W.   +9 more
openaire   +1 more source

Efficacy and safety of gepants in migraine management: a narrative review focusing on atogepant and rimegepant. [PDF]

J Oral Facial Pain Headache
Gautier A, Gicquel T, Mercerolle M, Le Daré B.   +3 more
europepmc   +1 more source

Acute Severe Pancolitis After Initiation of a Calcitonin Gene-Related Peptide Receptor Antagonist: A Case Report. [PDF]

ACG Case Rep J
Ravikulan A, Falvey J, Kubovy J.
europepmc   +1 more source

Hair loss in the era of CGRP inhibition: emerging evidence, mechanisms, and clinical implications. [PDF]

Front Neurol
Antanaitytė A, Jokubaitis M, Jokubaitė J, Ryliškienė K.   +3 more
europepmc   +1 more source

Chronic Migraine Resistance: A Case Report Highlights an Overlooked Factors in Family Medicine Clinics. [PDF]

Healthcare (Basel)
Alshareef MH.
europepmc   +1 more source

Corrigendum: Atogepant for migraine prevention: a meta-analysis of safety and efficacy in adults

Frontiers in Neurology
Adarsh Raja, Rabia Asim, Muhammad Hamza Shuja, Sandesh Raja, Tazheen Saleh Muhammad, Simran Bajaj, Abdul Hadi Ansari, Hamza Ali, Iffat Ambreen Magsi, Muhammad Hammad Faridi, Hamza Ali Hasnain Sheikh, Muhammad Junaid Imran, Muhammad Ahmed, Muhammad Sohaib Asghar, Muhammad Sohaib Asghar   +14 more
doaj   +1 more source

Post-marketing safety of CGRP monoclonal antibodies and gepants: A systematic review of spontaneous reporting system data. [PDF]

Headache
Giacon M, Terrazzino S.
europepmc   +1 more source

Retrospective Review of Dual CGRP-Targeted Regimens for Acute and Preventive Treatment of Migraines in a Veteran Population. [PDF]

Fed Pract
Forrest A, Billow D, Martin A.
europepmc   +1 more source

Drugs for Migraine Prophylaxis. [PDF]

Dtsch Arztebl Int
Diener HC, Grans J, Reuter U.
europepmc   +1 more source

CGRP-pathway exposure during the pre-EBP interval in spontaneous intracranial hypotension: an exploratory retrospective case series. [PDF]

BMC Neurol
Yin CY, Chang KH, Hsu YC, An YC, Yang IF, Yang FC.   +5 more
europepmc   +1 more source